Finance entity

Medicare

Company

Medicare is most often covered alongside Department of Health and Human Services, which appears in 1 of these 3 stories. That works out to roughly 0.1 stories per week across a 179-day span. They are less corroborated than the beat average, carrying 2.3 original sources each against 2.7 for the same window.

Last mentioned: 1d ago

Entity pulse

Recent coverage · Medicare

↑
3 stories
6 avg impact
33% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 33 percentage points.

  • 33% positive
  • 67% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Medicare

Medicare is most often covered alongside Department of Health and Human Services, which appears in 1 of these 3 stories. That works out to roughly 0.1 stories per week across a 179-day span. They are less corroborated than the beat average, carrying 2.3 original sources each against 2.7 for the same window. The clearest coverage concentration is economy: 1 of 3 stories, with the rest divided among 2 other categories. Their average consequence score of 6 runs below the beat's 6.2 for that window. Medicare appears in 3 tracked Finance stories published from February 24, 2026 through August 21, 2026.

Stories tracked
3
Per week
0.1
Sources per story
2.3

Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 3987 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Medicare. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Price Cut Effective

    Novo Nordisk's 50% list price reduction for Ozempic and Wegovy takes effect.

  2. Negotiation Deadline

    Expected announcement of final negotiated prices for the first round of Medicare drugs.

  3. Senate Hearing

    Novo Nordisk CEO Lars Fruergaard Jørgensen testifies on high U.S. drug prices.

  4. IRA Signed

    Inflation Reduction Act grants CMS authority to negotiate drug prices.

Stories mentioning Medicare 3

Medicare is linked from 3 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.